Skip to main content
. 2016 Dec 29;8(4):6994–7002. doi: 10.18632/oncotarget.14355

Figure 3. A receiver operating characteristic (ROC) curve predicting the ability of the circulating levels of miR-1 and cardiac troponin I (cTnI) to identify patients with cardiotoxicity from those with no cardiotoxicity.

Figure 3

Full line represents the area under the curve (AUC) of 0.851 (95% confidence interval, 0.729–0.933) for miR-1 and the dashed line an AUC of 0.544 (95% CI, 0.405-0.679) for cTnI. A pairwise comparison of ROC curves showed a difference between areas of 0.307 (95% CI, 0.116-0.497) and a p-value of 0.0016.